IL6 and relapsing-remitting multiple sclerosis: Similar results were obtained in HD subjects (Figure S4b), thus suggesting a cooperation of IL-6-mediated STAT3 activation and RelA/NF-κB in CD28-mediated up-regulation of c-myc expression in both HD and RRMS patients.